Clinical Application of the Dropplex EGFR Mutation Test v2 for EGFR Mutation Testing in Non-Small Cell Lung Cancer

Broadcast Date: May 18, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

To be implemented in the clinic, tests must be validated and approved through a regulatory process. Coverage and procedures for mutation types vary among the many available tests. There are various methods for EGFR mutation detection, including PCR-based methods, sequencing methods, IHC-based methods, and next-generation sequencing (NGS). The Droplex EGFR Mutation Test v2 using ddPCR is a test for quantitative detection of EGFR gene mutations in DNA extracted from FFPE tissue and plasma samples of non-small cell lung cancer patients.

In this Inside Precision Medicine webinar, our distinguished guest speaker Professor Yoon-La Choi, MD, PhD, will review the current status of EGFR mutation testing and discuss some issues regarding EGFR mutation testing.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.